Investors

Date	Name	Title	Type	Shares Traded	Price Range
Oct 13, 2010	sanofi	Beneficial Owner (10% or more)	Buy	1,017,401	28.00
May 18, 2010	sing george l	Director	Buy	5,000	28.44
May 18, 2010	sing george l	Director	Buy	2,500	28.64
Nov 13, 2009	sing george l	Director	Buy	10,000	18.78
Nov 13, 2009	sing george l	Director	Buy	2,500	18.68 - 18.72
Apr 30, 2012	aberman michael s	Officer	Automatic Sell	6,338	138.31
May 1, 2012	aberman michael s	Officer	Automatic Sell	6,162	134.52 - 135.29
Sep 2, 2011	aberman michael s	Officer	Automatic Sell	4,166	64.00
Sep 6, 2011	aberman michael s	Officer	Automatic Sell	4,957	65.76
Sep 7, 2011	aberman michael s	Officer	Automatic Sell	3,377	67.39 - 70.39
Nov 29, 2012	aberman michael s	Officer	Automatic Sell	4,430	182.20
Nov 30, 2012	aberman michael s	Officer	Automatic Sell	3,904	180.08 - 184.00
Dec 10, 2012	aberman michael s	Officer	Automatic Sell	4,132	182.68
Dec 11, 2012	aberman michael s	Officer	Automatic Sell	3,368	184.85 - 185.18
May 13, 2013	aberman michael s	Officer	Automatic Sell	6,971	275.97
May 14, 2013	aberman michael s	Officer	Automatic Sell	5,529	278.72 - 281.72
Jun 10, 2013	baker charles a	Director	Automatic Sell	15,000	250.06 - 257.99
Nov 26, 2012	baker charles a	Director	Automatic Sell	15,000	171.45 - 175.14
Sep 5, 2012	baker charles a	Director	Automatic Sell	1,286	150.00
Sep 6, 2012	baker charles a	Director	Automatic Sell	13,714	150.00
Showing 361-380 of 638 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.